Abstract
Introduction

Despite recent advances in the treatment of heart failure, cardiovascular diseases are the leading cause of morbidity and mortality throughout the world. Recent experiments with cell transplantation therapies have emerged as a potential strategy to treat ventricular dysfunction secondary to ischaemic cardiac injury [1]. The concept that adult cardiac stem cells (CSCs) may play a significant role in cardiac tissue homeostasis or responses to acute injury has been challenged by a series of experiments by fractionation of resident heart-derived cells, suggesting that adult CSCs could contribute at low levels to regenerate multiple cardiovascular lineages following direct transplantation into injured myocardium
.
Accumulated evidence suggests that transplantation of bone marrow-derived stem cells (BMCs) or skeletal myoblasts may contribute to the preservation of contractile function in some models of cardiac muscle injury [5] , although skeletal myoblasts lack direct cardiomyogenic activity when cultured alone in vitro or myocyte formation in vivo [6] . Most importantly, experimental analyses showed that skeletal myoblasts do not couple electronically with the host myocardium without cellular fusion events [7] . Furthermore, recent studies of adult BMCs in adopting cardiac cell fate has been highly controversial [8] [9] [10] [11] [14, 15] .
. The pathophysiological observations from several studies have indicated that BMCs integrated into the myocardium at very low frequency, if any, attributing to the functional improvement after myocardial infarction through paracrine effectors secretion rather than via direct myocyte differentiation and/or fusion in the transplanted hearts [11-13]. Despite these controversies regarding the efficacy of BMCs and myoblasts for cardiac regeneration, a number of randomized, multicenter clinical trials have conducted using autologous cells via intracoronary infusion or intramyocardial injection (Table 1). The results have shown either no benefit or small improvements in cardiac function, which were conferred unlikely from direct differentiation of the injected cells into cardiomyocytes
In the setting of identifying adult CSCs, several cell surface markers have been associated with cardiac progenitors [2, 3, 16] 
Cycling adult myocytes
Recent studies revealed that adult myocytes possess self-replicative capacity, documented by mitosis and cytokinesis under normal and pathophysiological conditions [17, 18] , and a small number of new myocytes could be formed after acute cardiac injury [19] . Early hypotheses proposed that new myocytes might be generated via re-entry to the cell cycle from pre-existing, mature myocytes through altered expression of D-type cyclins [20] [21] [22] [70] , prostate [71] , lung [72] , skeletal muscle [73] 
Intrinsic CSCs
Epicardial CSCs
The embryonic heart tube is formed by fusion of the primary heart fields and comprises an outer myocardial layer, including the epicardium, and an inner endocardial layer [83] . Myocardial precursor cells added to the anterior and posterior poles of the linear heart tube are derived from two lineages that segregate early from a common precursor [84, 85] [89] .
Developmental origin of CSCs
The heart is constructed from cells of a variety of origins including extracardiac sources. The major extracardiac contributions to the heart include cells of epicardial organ and the neural crest [90] . In contrast, the conduction system is not a neural crest derivative but is derived from cardiac myogenic precursors in chicks [91] [101] and smooth muscle differentiation [102] .
It will be of interest to determine if these factors are involved in the cellular development of other types of CSCs that was not originated from neural crest cells.
Signals control CSC proliferation
Cell-intrinsic properties are not the only determinants of stem cell fate. CSCs are tightly regulated by their microenvironment and tissue-specific signalling (Table 3). Gain-of-function studies revealed that activation of canonical Wnt signalling promoted Isl1
ϩ cardiac progenitor cell expansion with a concomitant increase in FGF signalling [103, 104] .
Studies of loss-of-function and gain-of-function by tissuespecific gene targeting in mouse models have implicated Wnt-␤-catenin signalling as one of the key regulators of precardiac mosederm-specification, Isl1
ϩ CSC self-renewal and subsequent [113, 114] , whereas later cytokines have broader cytoprotective effects than direct control of stem cell self-renewal through cell cycle regulation than has been previously appreciated [115] . [118] . [124] , abnormal responses to antigen stimulation in T cells [125] , reduction in engraftment of bone marrow transplants [126] and inhibition of myoblast fusion to promote differentiation [127] related to perturbed c-src and Fyn signalling [128, 129] . Evidence from a model of Sca-1 knockdown mice revealed that myocardial infarction leads to ventricular remodelling and poor survival; a phenotype that was recapitulated by studies using c-kit mutant mice (Fig. 3) 79, 165] Not detected in the heart [79, 125] Akt [79] Abcg2 ATP-binding cassette (ABC) transporters able to confer SP cells [166] Not detected in the heart [167] HIF-2␣ [168] [135] . Although whether the cardiovasculogenic abilities of epicardial progenitor cells strictly depend on a myocardium-derived signal or they are also sensitive to triggers from epicardial tissue itself in mammalian heart remain to be investigated, several signalling molecules have been implicated in the EMT process including ligand FGF17 and its receptor FGFR2 and FGFR4 in zebrafish heart regeneration [136] . Differentiation into the myocardial or epicardial lineage is mediated by the cooperative action of BMP and FGF signalling in chicken embryos [137] . [87, 89] [140] , which is consistent with a previous finding that ␤-catenin is a bifunctional protein involved in cell-cell adhesion [141] .
differentiation. An early study that reported conditional deletion of
The functional involvement of insulin-like growth factor-1 (IGF-1)/ IGF-1 receptor and hepatocyte growth factor (HGF)-c/Met systems in c-
Of the vascular growth factors that could potentially induce EMT, bFGF, epidermal growth factor (EGF), platelet-derived growth factor (PDGF)-BB and VEGF have been shown to stimulate epicardial cells in coronary morphogenesis
New advance in cardiac regeneration
Mammalian ES cells, including mouse [142] and human [143] [146] [147] [148] . A previous study has shown that another quartet of reprogramming factors, Oct4, Sox2, Nanog and Lin28, could successfully reproduce the pluripotent characteristics from human fibroblasts [149] . The latest report has shown that a modified protocol without c-Myc, which might increase the incidence of tumour development, could yield functionally similar iPS cells in mice [150] . Regardless [151, 152] .
Lastly, modulation of the microenvironment for myocardial tissue engineering subsequent to acute injury by any type of cell transplantation requires enhanced survival and resultant differentiation in vivo. Transplantation of differentiated cardiomyocytes [153] , human ES cells [154] or undifferentiated mesenchymal stem cells [155] 
